Literature DB >> 11583975

Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse).

E Baumgart1, I Vanhorebeek, M Grabenbauer, M Borgers, P E Declercq, H D Fahimi, M Baes.   

Abstract

Zellweger syndrome (cerebro-hepato-renal syndrome) is the most severe form of the peroxisomal biogenesis disorders leading to early death of the affected children. To study the pathogenetic mechanisms causing organ dysfunctions in Zellweger syndrome, we have recently developed a knockout-mouse model by disrupting the PEX5 gene, encoding the targeting receptor for most peroxisomal matrix proteins (M Baes, P Gressens, E Baumgart, P Carmeliet, M Casteels, M Fransen, P Evrard, D Fahimi, PE Declercq, D Collen, PP van Veldhoven, GP Mannaerts: A mouse model for Zellweger syndrome. Nat Genet 1997, 17:49-57). In this study, we present evidence that the absence of functional peroxisomes, causing a general defect in peroxisomal metabolism, leads to proliferation of pleomorphic mitochondria with severe alterations of the mitochondrial ultrastructure, changes in the expression and activities of mitochondrial respiratory chain complexes, and an increase in the heterogeneity of the mitochondrial compartment in various organs and specific cell types (eg, liver, proximal tubules of the kidney, adrenal cortex, heart, skeletal and smooth muscle cells, neutrophils). The changes of mitochondrial respiratory chain enzymes are accompanied by a marked increase of mitochondrial manganese-superoxide dismutase, as revealed by in situ hybridization and immunocytochemistry, suggesting increased production of reactive oxygen species in altered mitochondria. This increased oxidative stress induced probably by defective peroxisomal antioxidant mechanisms combined with accumulation of lipid intermediates of peroxisomal beta-oxidation system could contribute significantly to the pathogenesis of multiple organ dysfunctions in Zellweger syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583975      PMCID: PMC1850512          DOI: 10.1016/S0002-9440(10)62534-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  79 in total

Review 1.  Review: the cerebrohepatorenal syndrome of Zellweger, morphologic and metabolic aspects.

Authors:  R I Kelley
Journal:  Am J Med Genet       Date:  1983-12

2.  The cerebro-hepato-renal (Zellweger) syndrome: lamellar lipid profiles in adrenocortical, hepatic mesenchymal, astrocyte cells and increased levels of very long chain fatty acids and phytanic acid in the plasma.

Authors:  P Aubourg; O Robain; F Rocchiccioli; S Dancea; J Scotto
Journal:  J Neurol Sci       Date:  1985 May-Jun       Impact factor: 3.181

3.  Ultrastructure of the liver in th cerebrohepatorenal syndrome of Zellweger.

Authors:  W J Mooi; K P Dingemans; M A van den Bergh Weerman; A C Jöbsis; H S Heymans; P G Barth
Journal:  Ultrastruct Pathol       Date:  1983 Sep-Oct       Impact factor: 1.094

4.  Mitochondrial myopathy of cerebro-hepato-renal (Zellweger) syndrome.

Authors:  H B Sarnat; G Machin; H Z Darwish; S Z Rubin
Journal:  Can J Neurol Sci       Date:  1983-08       Impact factor: 2.104

5.  Biochemical studies in the liver and muscle of patients with Zellweger syndrome.

Authors:  J M Trijbels; J A Berden; L A Monnens; J L Willems; A J Janssen; R B Schutgens; M van den Broek-Van Essen
Journal:  Pediatr Res       Date:  1983-06       Impact factor: 3.756

6.  Mitochondrial myopathy with loosely coupled oxidative phosphorylation in a case of Zellweger syndrome. A cytochemical-ultrastructural study.

Authors:  J Müller-Höcker; J U Walther; K Bise; D Pongratz; G Hübner
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1984

Review 7.  Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans.

Authors:  J K Reddy; N D Lalwai
Journal:  Crit Rev Toxicol       Date:  1983       Impact factor: 5.635

8.  Fetal cerebrohepatorenal (Zellweger) syndrome: dysmorphic, radiologic, biochemical, and pathologic findings in four affected fetuses.

Authors:  J M Powers; H W Moser; A B Moser; J K Upshur; B F Bradford; S G Pai; P H Kohn; J Frias; C Tiffany
Journal:  Hum Pathol       Date:  1985-06       Impact factor: 3.466

9.  Ultrastructural localization of several phosphatases with cerium.

Authors:  J M Robinson; M J Karnovsky
Journal:  J Histochem Cytochem       Date:  1983-10       Impact factor: 2.479

10.  Peroxisomal defects in neonatal-onset and X-linked adrenoleukodystrophies.

Authors:  S Goldfischer; J Collins; I Rapin; B Coltoff-Schiller; C H Chang; M Nigro; V H Black; N B Javitt; H W Moser; P B Lazarow
Journal:  Science       Date:  1985-01-04       Impact factor: 47.728

View more
  69 in total

Review 1.  Organelle dynamics and dysfunction: A closer link between peroxisomes and mitochondria.

Authors:  F Camões; N A Bonekamp; H K Delille; M Schrader
Journal:  J Inherit Metab Dis       Date:  2008-12-12       Impact factor: 4.982

2.  Fis1 depletion in osteoarthritis impairs chondrocyte survival and peroxisomal and lysosomal function.

Authors:  Dongkyun Kim; Jinsoo Song; Yeonho Kang; Sujung Park; Yong-Il Kim; Seongae Kwak; Dongkwon Lim; Raekil Park; Churl-Hong Chun; Seong-Kyu Choe; Eun-Jung Jin
Journal:  J Mol Med (Berl)       Date:  2016-08-06       Impact factor: 4.599

Review 3.  A new pathway for mitochondrial quality control: mitochondrial-derived vesicles.

Authors:  Ayumu Sugiura; Gian-Luca McLelland; Edward A Fon; Heidi M McBride
Journal:  EMBO J       Date:  2014-08-08       Impact factor: 11.598

Review 4.  Mendelian neurodegenerative disease genes involved in autophagy.

Authors:  Lidia Wróbel; Sandra Malmgren Hill; Claudia Puri; Sung Min Son; Motoki Fujimaki; Ye Zhu; Eleanna Stamatakou; Farah Siddiqi; Marian Fernandez-Estevez; Marco M Manni; So Jung Park; Julien Villeneuve; David Chaim Rubinsztein
Journal:  Cell Discov       Date:  2020-05-05       Impact factor: 10.849

5.  Substantial Decrease in Plasmalogen in the Heart Associated with Tafazzin Deficiency.

Authors:  Tomohiro Kimura; Atsuko K Kimura; Mindong Ren; Bob Berno; Yang Xu; Michael Schlame; Richard M Epand
Journal:  Biochemistry       Date:  2018-03-30       Impact factor: 3.162

6.  Modulation of peroxisome proliferator-activated receptor-alpha activity by N-acetyl cysteine attenuates inhibition of oligodendrocyte development in lipopolysaccharide stimulated mixed glial cultures.

Authors:  Manjeet K Paintlia; Ajaib S Paintlia; Mushfiquddin Khan; Inderjit Singh; Avtar K Singh
Journal:  J Neurochem       Date:  2008-01-12       Impact factor: 5.372

Review 7.  Mammalian peroxisomes and reactive oxygen species.

Authors:  Michael Schrader; H Dariush Fahimi
Journal:  Histochem Cell Biol       Date:  2004-07-08       Impact factor: 4.304

8.  alpha-Synuclein abnormalities in mouse models of peroxisome biogenesis disorders.

Authors:  Eugenia Yakunin; Ann Moser; Virginie Loeb; Ann Saada; Phyllis Faust; Denis I Crane; Myriam Baes; Ronit Sharon
Journal:  J Neurosci Res       Date:  2010-03       Impact factor: 4.164

9.  Lipopolysaccharide-induced peroxisomal dysfunction exacerbates cerebral white matter injury: attenuation by N-acetyl cysteine.

Authors:  Manjeet K Paintlia; Ajaib S Paintlia; Miguel A Contreras; Inderjit Singh; Avtar K Singh
Journal:  Exp Neurol       Date:  2007-12-23       Impact factor: 5.330

Review 10.  Bile acids: the role of peroxisomes.

Authors:  Sacha Ferdinandusse; Simone Denis; Phyllis L Faust; Ronald J A Wanders
Journal:  J Lipid Res       Date:  2009-04-08       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.